Abstract
A highly purified preparation of human pituitary luteinizing hormone was treated with neuraminidase resulting in 94% removal of the sialic acid moiety. This led to a marked loss of biologic activity as measured by the ventral prostate weight and ovarian ascorbic acid depletion assays, and enhancement of the radioimmunologic activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biochemical and Biophysical Research Communications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
